Biopharmaceutical CMO and CRO market insights on trends, drivers, and opportunities
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Will The Market Value Of The Biopharmaceutical CMO And CRO Market Grow Between 2026 And 2030?
The biopharmaceutical cmo and cro market has demonstrated robust expansion recently. Its size is anticipated to increase from $35.6 billion in 2025 to $38.01 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.8%. This historical growth can be linked to several contributing factors, including the increasing complexity inherent in biologic drug development, the rising R&D expenditures for biopharmaceutical companies, the broader scope of clinical trial activities, the advancement in biosimilar development, and the presence of specialized contract service providers.
The biopharmaceutical cmo and cro market is projected to experience robust expansion over the coming years. This market is set to reach $48.79 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this anticipated growth include a heightened demand for sophisticated biologics production, increased capital allocation for cell and gene therapies, the broadening of worldwide clinical trial pipelines, an intensified emphasis on strategies for quicker market entry, and the greater uptake of digitalized CRO offerings. Key trends expected during this forecast timeframe encompass the expanding practice of outsourcing biologic drug production, an escalating need for comprehensive end-to-end contract research solutions, a developing preference for adaptable manufacturing capabilities, the broadening of support for cell and gene therapy development, and a reinforced focus on services ensuring regulatory adherence.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-and-cro-global-market-report
Which Drivers Are Supporting The Biopharmaceutical CMO And CRO Market Growth?
Increased allocation of funds towards research and development is projected to boost the expansion of the biopharmaceutical CMO and CRO market in the future. This increase in R&D funding stems from various reasons, including the push for novel solutions, intense competition, the necessity to meet changing market requirements, and governmental support. Such investments empower CMOs and CROs to develop improved manufacturing processes and research protocols, consequently enhancing their capacities and operational effectiveness. This focus on innovation attracts and retains customers by offering advanced solutions, all while ensuring adherence to regulatory standards. For instance, in September 2025, according to Eurostat, the Luxembourg-based statistical agency, the EU spent about $456 billion USD on research and development (R&D) in 2023 (€389 billion), and R&D expenditure relative to GDP rose to 2.26%, up from 2.22% in the previous year. Consequently, the increased spending on research and development is propelling the expansion of the biopharmaceutical CMO and CRO market.
How Is The Biopharmaceutical CMO And CRO Market Organized By Segment Classification?
The biopharmaceutical cmo and cro market covered in this report is segmented –
1) By Product: Biologics, Biosimilars
2) By Service Type: Contract Manufacturing, Contract Research
3) By Source: Mammalian, Non-Mammalian
Subsegments:
1) By Biologics: Monoclonal Antibodies (mAbs), Vaccines, Recombinant Proteins, Cell and Gene Therapies, Antibody-Drug Conjugates (ADCs), Therapeutic Enzymes
2) By Biosimilars: Biosimilar Monoclonal Antibodies, Biosimilar Insulins, Biosimilar Growth Hormones, Biosimilar Erythropoietins, Biosimilar Granulocyte Colony-Stimulating Factors (G-CSFs)
Which Trends Are Expected To Impact The Biopharmaceutical CMO And CRO Market?
Leading entities within the biopharmaceutical CMO and CRO market are establishing strategic collaborations with the goal of improving service offerings, boosting operational efficiencies, and speeding up drug development processes for biopharmaceutical organizations. These strategic partnerships represent a method where businesses utilize one another’s capabilities and assets to secure shared advantages and collective achievement. An illustrative example is seen in June 2024, when Abzena plc., a UK-based biopharmaceutical company, entered into a partnership with Argonaut Manufacturing Services Inc., a US-based contract manufacturing organization (CMO), for the purpose of combining drug development and manufacturing solutions tailored for clients. Through this collaboration, their objective is to deliver expedited, comprehensive drug development and manufacturing services designed to increase effectiveness, decrease expenditures, and simplify biopharmaceutical production for their clientele.
Who Are The Industry Participants Involved In The Biopharmaceutical CMO And CRO Market?
Major companies operating in the biopharmaceutical cmo and cro market are Thermo Fisher Scientific Inc., Boehringer Ingelheim International GmbH, Eurofins Scientific SE, Lonza Group AG, Syneos Health Inc., Catalent Inc., Charles River Laboratories International Inc., Parexel International (MA) Corporation, Samsung Biologics Co. Ltd., CELLTRION INC., Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies UK Limited, Almac Group, Pharmaron Beijing Co. Ltd., Worldwide Clinical Trials, KBI Biopharma, Inotiv Inc., Caidya, Rentschler Biopharma SE, Celerion Inc., TFS HEALTHCARE LIMITED
Get The Full Biopharmaceutical CMO And CRO Market Report:
https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-and-cro-global-market-report
Which Region Holds The Highest Market Share In The Biopharmaceutical CMO And CRO Market?
North America was the largest region in the biopharmaceutical CMO and CRO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical cmo and cro market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Biopharmaceutical CMO And CRO Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-and-cro-global-market-report
Browse Through More Reports Similar to the Global Biopharmaceutical CMO And CRO Market 2026, By The Business Research Company
Biopharmaceutical Third Party Logistics Market Report 2026
Biopharmaceuticals Contract Manufacturing Market Report 2026
Lyophilization Services For Biopharmaceuticals Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
